A study to evaluate drug combination therapy in gynecologic cancer
Tashanna Myers, MD
D’Amour Center for Cancer Care
3350 Main Street
Baystate Franklin Medical Center
164 High Street
The purpose of this study is to find out if the drug combination of paclitaxel, carboplatin and metformin works better than paclitaxel and carboplatin alone and to find out what side effects are caused by treatment with these drugs.
Measurable Stage III, measurable Stage IVA, StageIVB (with or without measurable disease) or recurrent (with or without measurable disease) endometrial carcinoma